Log in
Enquire now
‌

US Patent 11426391 Pharmaceutical compositions

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
114263910
Patent Inventor Names
Magnus Brisander0
Helene Dérand0
Gérald Jesson0
Martin Malmsten0
Mustafa Demirbüker0
Date of Patent
August 30, 2022
0
Patent Application Number
176711570
Date Filed
February 14, 2022
0
Patent Citations
‌
US Patent 11241419 Pharmaceutical compositions
‌
US Patent 10314830 Pharmaceutical compositions
Patent Primary Examiner
‌
Jeffrey T. Palenik
0
CPC Code
‌
A61K 31/44
0
‌
A61K 31/4439
0
‌
A61K 31/444
0
‌
A61K 31/4545
0
‌
A61K 31/506
0
‌
A61K 31/517
0
‌
A61K 31/5377
0
‌
A61K 47/32
0
...

The present invention relates to the field of methods for providing pharmaceutical compositions comprising poorly water-soluble drugs. In particular the present invention relates to compositions comprising stable, amorphous hybrid nanoparticles, comprising at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix-forming component, useful in pharmaceutical compositions and in therapy.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11426391 Pharmaceutical compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.